SCIB1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SCIB1, covering 2025-12-19 to 2025-12-19. Get the full timeline:
Most recent: Clinical Trial Update: SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study) [Phase 2]